Zhifei Biological secures new vaccine invention patent
Chongqing Zhifei Biological Products Co., Ltd., along with its wholly-owned subsidiaries Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. and Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd., announced the acquisition of an invention patent certificate.
The patent, titled "A vaccine and its preparation method," was applied for on February 4, 2024, and authorized for announcement on October 21, 2025. The patent holders are Zhifei Biological, Zhifei Green Bamboo, and Zhifei Longcom.
This invention patent was obtained during the research and development process of products in the company's R&D pipeline. The company asserts that while the acquisition of this patent certificate will not have a significant impact on its recent production and operations, it is beneficial for further enhancing the company's intellectual property protection system.
The company aims to leverage this patent to fully utilize its independent intellectual property advantages, foster technological innovation, and strengthen its core competitiveness in the market.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Chongqing Zhifei Biological Products publishes news
Free account required • Unsubscribe anytime